RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,943,262 | -70.8% | 907,616 | -71.4% | 0.04% | -68.4% |
| Q2 2023 | $23,740,997 | -26.2% | 3,178,179 | -34.1% | 0.13% | -39.3% |
| Q1 2023 | $32,187,653 | -13.5% | 4,825,735 | 0.0% | 0.22% | +25.9% |
| Q4 2022 | $37,206,417 | -23.8% | 4,825,735 | +5.2% | 0.17% | -39.6% |
| Q3 2022 | $48,809,000 | +30.7% | 4,587,274 | 0.0% | 0.29% | -50.1% |
| Q2 2022 | $37,341,000 | +13.7% | 4,587,274 | 0.0% | 0.58% | +43.5% |
| Q1 2022 | $32,845,000 | -51.1% | 4,587,274 | +16.9% | 0.40% | -40.9% |
| Q4 2021 | $67,213,000 | -25.6% | 3,923,713 | 0.0% | 0.68% | +78.9% |
| Q3 2021 | $90,285,000 | -35.9% | 3,923,713 | +1.7% | 0.38% | -51.4% |
| Q2 2021 | $140,839,000 | – | 3,858,617 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 5,977,631 | $42,800,000 | 100.00% |
| Two Sigma Ventures, LP | 1,806,800 | $12,937,000 | 74.73% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $28,290,000 | 31.54% |
| MV Management XI, L.L.C. | 1,971,908 | $14,119,000 | 9.80% |
| Data Collective IV GP, LLC | 5,941,120 | $42,538,000 | 9.03% |
| ArchPoint Investors | 1,267,430 | $9,075,000 | 3.13% |
| MIC Capital Management UK LLP | 1,388,889 | $9,944,000 | 1.94% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $10,806,000 | 1.09% |
| Samsara BioCapital, LLC | 539,236 | $3,861,000 | 0.97% |
| Pinz Capital Management, LP | 142,168 | $1,018,000 | 0.64% |